Search clinical trials for: erlotinib/placebo
Total 54784 results
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedBrain and Central Nervous System TumorsUnited States
-
Samsung Medical CenterUnknown
-
Henry Ford Health SystemGenentech, Inc.TerminatedHead and Neck Cancer | Carcinoma, Squamous Cell
-
University of CincinnatiGenentech, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
Dana-Farber Cancer InstituteAstellas Pharma IncTerminatedNon-Small Cell Lung Cancer | Epidermal Growth Factor ReceptorUnited States
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States, Germany, Spain, Belgium, France, United Kingdom, Netherlands, Italy, Israel, Korea, Republic of
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerPortugal
-
Oncology Specialists, S.C.CompletedProstate CancerUnited States
-
Groupe Francophone des MyelodysplasiesRoche Pharma AGCompleted
-
University of UtahCompleted
-
Wu Jieping Medical FoundationZhejiang Cancer Hospital; Fudan University; Shanghai Chest Hospital; Shanghai Pulmonary... and other collaboratorsUnknownNon Small Cell Lung Cancer, OligometastaticChina
-
Ontario Clinical Oncology Group (OCOG)Roche Pharma AGCompletedNon-small Cell Lung CancerCanada
-
Zhejiang Cancer HospitalUnknownNon-small Cell Lung CancerChina
-
Amsterdam UMC, location VUmcCompletedNon-Small Cell Lung Cancer | Brain MetastasesNetherlands
-
Guangdong Provincial People's HospitalUnknownNon-Small Cell Lung Cancer | Brain Metastases
-
Hospital of NavarraDr. Enrique Martínez LópezUnknownCarcinoma, Non-Small-Cell LungSpain
-
University of Colorado, DenverPOM Wonderful LLCCompletedType 2 Diabetes MellitusUnited States
-
University of PittsburghOSI PharmaceuticalsCompletedHead and Neck Squamous Cell CarcinomaUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingHER2-negative Breast CancerChina
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingCervical Cancer
-
University of OklahomaOSI PharmaceuticalsTerminatedPolycythemia VeraUnited States
-
M.D. Anderson Cancer CenterUnited States Department of DefenseCompletedLung CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); OSI PharmaceuticalsCompletedBladder CancerUnited States
-
University of Alabama at BirminghamOSI PharmaceuticalsTerminatedPancreatic CancerUnited States
-
SCRI Development Innovations, LLCGlaxoSmithKline; OSI PharmaceuticalsCompletedNon Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
Michael PradosNational Cancer Institute (NCI); Genentech, Inc.TerminatedAdult Brain TumorsUnited States
-
NovaceaSchering-PloughSuspended
-
NCIC Clinical Trials GroupRoche Pharma AGCompleted
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Spain, Taiwan, China, United Kingdom, Denmark, Canada, Korea, Republic of, Germany, Italy, Netherlands, Singapore, Austria, France, Portugal, Greece, India, Mexico, Hungary, Turkey, Argentina, Chile, Ireland
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerItaly
-
Northwell HealthGenentech, Inc.CompletedGlioblastoma Multiforme | Anaplastic AstrocytomaUnited States
-
Alaunos TherapeuticsUnknownAdvanced Solid TumorsUnited States
-
Andrew B Lassman, MDGenentech, Inc.; OSI PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Skin Squamous Cell Carcinoma | Recurrent Skin Squamous Cell CarcinomaUnited States
-
Montefiore Medical CenterGenentech, Inc.Completed
-
Pasi A. Janne, MD, PhDMassachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaboratorsCompletedAdenocarcinoma | Non-small Cell Lung CancerUnited States
-
OSI PharmaceuticalsTerminatedEpendymomaUnited States, Canada, United Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Kyowa Kirin Co., Ltd.CompletedAdvanced/Recurrent Non-small-cell Lung CancerJapan
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBulgaria
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerFinland
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerItaly, Spain, Netherlands, France, Germany, United Kingdom
-
PfizerTerminatedCarcinoma, Non-Small-Cell Lung | Carcinoma, Squamous Cell | Carcinoma, Large Cell | Carcinoma, Adenosquamous CellUnited States, Bulgaria, Italy, Spain, Ukraine, Belgium, France, Ireland, Korea, Republic of, Poland, Russian Federation, United Kingdom, Hungary, Serbia, Taiwan, Canada, South Africa, Brazil, Romania, Greece, Puerto Rico, Czech Republic and more
-
Hoffmann-La RocheTerminatedNon-Small Cell Lung CancerUnited States, Canada, France, Poland
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
AZ-VUBHoffmann-La RocheUnknownLung Neoplasms | Non-Small Cell Lung Cancer | Adenocarcinoma, Bronchiolo-AlveolarBelgium
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
University of California, San FranciscoGenentech, Inc.CompletedGlioblastoma Multiforme | GliosarcomaUnited States